130 related articles for article (PubMed ID: 721317)
1. Immunotherapy with an intralesionally administered synthetic cord factor analogue.
Yarkoni E; Rapp HJ; Polonsky J; Lederer E
Int J Cancer; 1978 Nov; 22(5):564-9. PubMed ID: 721317
[TBL] [Abstract][Full Text] [Related]
2. Regression of a murine fibrosarcoma after intralesional injection of a synthetic C39 glycolipid related to cord factor.
Yarkoni E; Rapp HJ; Polonsky J; Varenne J; Lederer E
Infect Immun; 1979 Nov; 26(2):462-6. PubMed ID: 546783
[TBL] [Abstract][Full Text] [Related]
3. Tumor regression after intralesional injection of emulsified trehalose-6,6'-dimycolate (cord factor): efficacy increases with oil concentration.
Yarkoni E; Meltzer MS; Rapp HJ
Int J Cancer; 1977 Jun; 19(6):818-21. PubMed ID: 326683
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy of an ascitic rat hepatoma with cord factor (trehalose-6, 6'-dimycolate) and synthetic analogues.
Pimm MV; Baldwin RW; Polonsky J; Lederer E
Int J Cancer; 1979 Dec; 24(6):780-5. PubMed ID: 544531
[TBL] [Abstract][Full Text] [Related]
5. Tumor regression after intralesional injection of mycobacterial components emulsified in 2,6,10,15,19,23-hexamethyl-2,6,10,14,18,22-tetracosahexaene (squalene), 2,6,10,15,19,23-hexamethyltetracosane (squalane), peanut oil, or mineral oil.
Yarkoni E; Rapp HJ
Cancer Res; 1979 May; 39(5):1518-20. PubMed ID: 427795
[TBL] [Abstract][Full Text] [Related]
6. Treatment of mice with lung metastasis from a dermally implanted fibrosarcoma: comparison of intratumoral trehalose-6,6'-dimycolate (cord factor) and surgery.
Yarkoni E; Rapp HJ; Hunter JT
Eur J Cancer (1965); 1981 Mar; 17(3):291-5. PubMed ID: 7262166
[No Abstract] [Full Text] [Related]
7. Regression of tumors in guinea pigs after treatment with synthetic muramyl dipeptides and trehalose dimycolate.
McLaughlin CA; Schwartzman SM; Horner BL; Jones GH; Moffatt JG; Nestor JJ; Tegg D
Science; 1980 Apr; 208(4442):415-6. PubMed ID: 7189295
[TBL] [Abstract][Full Text] [Related]
8. Regression of a transplanted guinea pig hepatoma after intralesional injection of an emulsified mixture of endotoxin and mycobacterial sulfolipid.
Yarkoni E; Goren MB; Rapp HJ
Infect Immun; 1979 May; 24(2):357-62. PubMed ID: 378852
[TBL] [Abstract][Full Text] [Related]
9. Influence of oil concentration on the efficacy of tumor regression by emulsified components of mycobacteria.
Yarkoni E; Rapp HJ
Cancer Res; 1979 Feb; 39(2 Pt 1):535-7. PubMed ID: 761228
[TBL] [Abstract][Full Text] [Related]
10. Nonspecific resistance against infection with Salmonella typhi and Salmonella typhimurium induced in mice by cord factor (trehalose-6,6'-dimycolate) and its analogues.
Yarkoni E; Bekierkunst A
Infect Immun; 1976 Nov; 14(5):1125-9. PubMed ID: 789240
[TBL] [Abstract][Full Text] [Related]
11. Granuloma formation in lungs of mice after intravenous administration of emulsified trehalose-6,6'-dimycolate (cord factor): reaction intensity depends on size distribution of the oil droplets.
Yarkoni E; Rapp HJ
Infect Immun; 1977 Nov; 18(2):552-4. PubMed ID: 924683
[TBL] [Abstract][Full Text] [Related]
12. Toxicity of emulsified trehalose-6,6'-dimycolate (cord factor) in mice depends on size distribution of mineral oil droplets.
Yarkoni E; Rapp HJ
Infect Immun; 1978 Jun; 20(3):856-60. PubMed ID: 669824
[TBL] [Abstract][Full Text] [Related]
13. Granuloma-forming activity and antitumor activity of newly isolated mycoloyl glycolipid from Rhodococcus terrae 70012 (Rt. GM-2).
Natsuhara Y; Yoshinaga J; Shogaki T; Sumi-Nishikawa Y; Kurano S; Kato Y; Kaneda K; Oka S; Yano I
Microbiol Immunol; 1990; 34(1):45-53. PubMed ID: 2325578
[TBL] [Abstract][Full Text] [Related]
14. Responses of tumors induced in inbred guinea pig strain JY=1 and strain Hartley/F to BCG.
Kataoka T; Tokunaga T; Murohashi T
J Natl Cancer Inst; 1977 Mar; 58(3):803-8. PubMed ID: 320348
[TBL] [Abstract][Full Text] [Related]
15. Influence of surfactant concentration on the antitumor activity of emulsified components of mycobacteria.
Yarkoni E; Rapp HJ
Cancer Res; 1980 Apr; 40(4):975-8. PubMed ID: 7357563
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy of experimental cancer with a mixture of synthetic muramyl dipeptide and trehalose dimycolate.
Yarkoni E; Lederer E; Rapp HJ
Infect Immun; 1981 Apr; 32(1):273-6. PubMed ID: 7216489
[TBL] [Abstract][Full Text] [Related]
17. Histopathology of tumor regression by cord factor, turpentine or endotoxin, dissociation of therapy and granuloma formation.
Yarkoni E; Ruco LP; Rapp HJ; Meltzer MS
Eur J Cancer (1965); 1979 Nov; 15(11):1401-7. PubMed ID: 527631
[No Abstract] [Full Text] [Related]
18. [Antitumor effect of a synthetic cord factor, 6,6'-di-O-decanoyl-alpha, alpha-trehalose (SS 554) in mice].
Kohya H; Ishii F; Takano S; Katori T; Ebina T; Ishida N
Gan To Kagaku Ryoho; 1986 May; 13(5):1897-904. PubMed ID: 3754712
[TBL] [Abstract][Full Text] [Related]
19. Induction of pulmonary granulomas, macrophage procoagulant activity, and tumor necrosis factor-alpha by trehalose glycolipids.
Behling CA; Perez RL; Kidd MR; Staton GW; Hunter RL
Ann Clin Lab Sci; 1993; 23(4):256-66. PubMed ID: 8373130
[TBL] [Abstract][Full Text] [Related]
20. Role of interferon in the augmented resistance of trehalose-6,6'-dimycolate-treated mice to influenza virus infection.
Azuma M; Suzutani T; Sazaki K; Yoshida I; Sakuma T; Yoshida T
J Gen Virol; 1987 Mar; 68 ( Pt 3)():835-43. PubMed ID: 3493326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
